Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CRSP
Stock Latest News
The Fly
FDA to speed up gene editing therapy approvals, Bloomberg reports
2d ago
CRSP
EDIT
Premium
Company Announcements
Crispr Therapeutics’ Long-term Study on CAR T Therapies: A Market Game Changer?
6d ago
CRSP
Premium
The Fly
Video: This stock is dragging down the in vivo gene editing therapy space
6d ago
MGX
BEAM
Premium
The Fly
Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
6d ago
MGX
CRSP
Premium
The Fly
Intellia Therapeutics price target lowered to $30 from $36 at BofA
6d ago
BEAM
CRBU
Premium
Pre-Earnings
Crispr Therapeutics (CRSP) Q3 Earnings Cheat Sheet
6d ago
CRSP
Premium
Weekend Updates
Crispr Therapeutics AG Faces Stock Price Slump
8d ago
CRSP
Premium
The Fly
Crispr Therapeutics price target raised to $93 from $78 at BofA
16d ago
CRSP
Premium
Company Announcements
Crispr Therapeutics AG Files $600M Share Offering
18d ago
8K
CRSP
Premium
The Fly
Crispr Therapeutics price target raised to $75 from $65 at Wells Fargo
20d ago
CRSP
Premium
Ratings
Crispr Therapeutics AG: Promising Advancements in Gene Editing and Strategic Market Entry Justify Buy Rating
20d ago
CRSP
Premium
Ratings
Crispr Therapeutics AG: Buy Rating Backed by Innovative SyNTase Platform and Promising Preclinical Data
23d ago
CRSP
Premium
Ratings
Crispr Therapeutics AG: Promising Advancements in Gene Editing Justify Buy Rating
23d ago
CRSP
Premium
The Fly
Crispr presents new preclinical data from SyNTase gene editing platform
23d ago
CRSP
Premium
The Fly
Crispr Therapeutics to present preclinical data on AATD at ESGCT 2025
1M ago
CRSP
Premium
Ratings
Crispr Therapeutics AG: Buy Rating Backed by Promising Developments and Market Opportunities
1M ago
CRSP
Premium
The Fly
Crispr, Sirius announce first patient dosed in SRSD107 Phase 2 trial
1M ago
CRSP
Premium
Weekend Updates
Crispr Therapeutics AG Surges Amid Analyst Praise
1M ago
CRSP
Premium
Weekend Updates
Deckers, Credo, Crispr, AeroVironment, Abercrombie: Trending by Analysts
1M ago
ANF
AVAV
Premium
The Fly
Private Markets: Dyna Robotics raises $120M from Nvidia, Amazon
1M ago
V
MA
Premium
Market News
Cathie Wood Invests $37M into Biotech Stocks, Trims Stake in KTOS, TEM, and ROKU Stocks
2M ago
TEM
ARCT
Premium
Ratings
Crispr Therapeutics AG: Promising Growth and Strategic Opportunities Justify Buy Rating
2M ago
CRSP
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
